作者: Marley L Watson , Kevin Hall , Matthew R Watson , None
DOI: 10.1016/BS.SEDA.2019.07.018
关键词:
摘要: Abstract This is a review of current literature published between January 2018 and 2019 including any publications regarding adverse effects related to corticotrophins, corticosteroids, prostaglandins. The following medications are included: glucocorticoids, the prostaglandins alprostadil (PGE1), epoprostenol (PGI1 analogue), iloprost (PGI2 misoprostol (PGE1 treprostinil analogue).